Protekt Therapeutics
Dalia (Dalik) Pinkert, PhD, serves as the Senior Director of CMC and Medicinal Chemistry at ProteKt Therapeutics since December 2019, while also providing consultancy to the pharmaceutical industry through a self-employed freelance role since April 2019, focusing on synthetic, medicinal, and analytical chemistry. Prior experience includes positions as Senior Project Manager and Chemistry Expert at Stratasys (2017-2018) and various roles at Teva Pharmaceuticals between 2001 and 2017, including Senior Manager and Development Scientist in the Analytical department and Team Leader in the Process Development Department. Dalia holds a Doctor of Philosophy in Medicinal Organic Chemistry and a Bachelor's degree in the same field, both from Bar-Ilan University, completed in 2001 and 1995, respectively.
This person is not in any teams
This person is not in any offices
Protekt Therapeutics
ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.